Vildanat M 50mg/500mg Tablet is an antidiabetic drug that belongs to a class of drugs called dipeptidyl peptidase-4 inhibitors containing the active ingredient Vildagliptin. This medication is indicated in patients with type 2 diabetes mellitus. Type 2 diabetes is a condition in which the blood sugar (glucose) level is high in the body. It occurs when the body cells become resistant to the effect of insulin. As a result of this insulin resistance, the blood glucose level in the body increases. In type 2 diabetes, the body does not make sufficient insulin, or the insulin that is produced is not used well. It is otherwise also known as non-insulin-dependent diabetes mellitus, and since it usually occurs past middle age, it is also widely referred to as mature onset diabetes. If you suspect an allergy to the drug or its components, avoid taking the medicine and consult your doctor. This drug is not recommended in individuals with diabetic ketoacidosis, a serious complication of diabetes caused by high blood sugar and the presence of ketones in the blood. If you are taking an anti-diabetic medicine known as sulphonylurea if you are on dialysis due to kidney problems or liver disease, or if you have had heart failure or a history of pancreatic disease. Your doctor may need to adjust the drug dose when taking it together with Vildanat M 50mg/500mg Tablet to prevent low blood glucose (hypoglycemia). This drug should not be used during pregnancy unless specifically advised by your physician. Notify your physician if you are pregnant, suspecting, or planning for the pregnancy. It is not known whether Vildanat M 50mg/500mg Tablet passes into breast milk. You should not use this drug if you are breastfeeding or plan to breastfeed. This medication is not to be taken by children and adolescents under 18. This recommendation is likely due to this age group's limited safety and efficacy data.